Katherine Ruffner

3.9k citations
31 papers · 2.0k · 2 hit papers · h-index 12

Impact in

  • Oncology top 5%
    • CAR-T cell therapy research
  • Genetics top 2%
    • Virus-based gene therapy research

Papers in

    • Hematopoietic Stem Cell Transplantation 10
    • Acute Myeloid Leukemia Research 8
    • Chronic Myeloid Leukemia Treatments 3
    • Neutropenia and Cancer Infections 3

Katherine Ruffner

29 papers receiving 1.9k citations

Katherine Ruffner's Hit Papers

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study 2013 · 477 citations
4770+11+23Years since publication250500750

Peers

Katherine Ruffner
Comparison fields: 5 of 84
  • Oncology 823
  • Genetics 771
  • Neurology 299
  • Hematology 209
  • Epidemiology 577
Replace R C Moen with:
R C Moen United States
Neil L. Berinstein Canada
Lloyd Hutchinson United States
Ludvik R. Donner United States
T C Meeker United States
Anne I.J. Arens Netherlands
Geoffrey R. Kitchingman United States
Raffaella Meazza Italy
Torsten Dreier Belgium
Joyce D. Fingeroth United States
Katherine Ruffner relative to R C Moen United States R C Moen's profile →
Citations per field
00.5×12.3×
R C Moen · 1×
Citations per year

Countries citing papers authored by Katherine Ruffner

Since Specialization
Citations

This map shows the geographic impact of Katherine Ruffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Ruffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Ruffner more than expected).

Fields of papers citing papers by Katherine Ruffner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Ruffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Ruffner. The network helps show where Katherine Ruffner may publish in the future.

Co-authors

The 25 scholars most cited alongside Katherine Ruffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katherine Ruffner Line = papers co-authored together Katherine Ruffner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Hit paper breakdown →
1991795
2
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Hit paper breakdown →
2013477
3 1992109
4 2005107
5 2011102
6 200789
7 199065
8 199353
9 200535
10 199028
11
Current uses of monoclonal antibodies in the treatment of acute leukemia.
200025
12 200515
13
Immunosuppressive effects of (131)I-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models.
200110
14 20227
15 20076
16 20106
17 20045
18 20203
19 20123
20
Experimental therapy of human glioma by means of a genetically engineered virus mutant
19912

About Katherine Ruffner

Katherine Ruffner is a scholar working on Hematology, Oncology, Epidemiology, Genetics and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (8 papers), Herpesvirus Infections and Treatments (6 papers), Virus-based gene therapy research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Oncology (823 citations), Genetics (771 citations), Neurology (299 citations), Hematology (209 citations) and Epidemiology (577 citations). Katherine Ruffner has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Donald M. Coen, Robert L. Martuza, James M. Markert, Amy Malick, Charles B. C. Hwang, Keith D. Wilner, Charlotte H. Ahern, Stephan D. Voss, Susan M. Blaney and Yaël P. Mossé. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Journal of Virology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact